We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Absorption Comparison on Equivalency Value of Genepro Gen2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02919657
Recruitment Status : Completed
First Posted : September 29, 2016
Results First Posted : December 1, 2016
Last Update Posted : April 24, 2017
Sponsor:
Information provided by (Responsible Party):
Musclegen Research, Inc.

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Genepro Gen2 Absorption and Protein Value Clinical Trial.

Condition or disease Intervention/treatment Phase
Analysis, Event History Absorption; Disorder, Protein Dietary Supplement: Genepro Protein Dietary Supplement: Whey Protein Phase 4

Detailed Description:

Objective: To prove the absorbability and usability of Genepro Gen2 Protein and compared to whey isolate. This study is intended to show the equivalent value of Genepro Gen2 as compared to whey protein isolate (1 tablespoon Genepro Gen2 compared to 30g serving of whey isolate)

Parameters: This study encompasses a 12-week program that follows 20 gastric bypass patients that have undergone weight loss surgery. We took a baseline blood analysis prior to the start of the study and subsequently we took weekly blood work to chart and register the findings. For this study we will only be doing the weekly analysis on blood protein levels by utilizing Spectrophotometry. The target blood protein range is 6.1-8.7 g/dL this test is administered while fasting.

Participants: 20 Post Op Gastric Bypass patients. 10 men, 10 women. All participants were between the ages of 30-46 years of age. All participants have been post operation from their weight loss surgery for a minimum of 3 months prior to the start of the study and no longer than 12 months at the start of the study.

Gathering Results: 10 subjects will receive Genepro Gen 2 protein (1 tablespoon serving) for the first 6 weeks of the study and for the last six weeks, they will receive 30g of Whey protein. In conjunction the other group of 10 subjects will receive 30g whey protein the first 6 weeks of the study and Genepro Gen2 protein the final six weeks. Weekly blood analysis will determine blood protein levels.

Diet: Diet guidelines limit the calories you consume while providing you with balanced meals to help prevent nutritional deficiencies and preserve your muscle tissue. Each patient tolerates suggested foods differently.

Daily calories should be between 600 to 700 for the duration of this study. Each subject is to follow a diet low in calories, fats and sweets. The goal for each subject is to consume a minimum of 65 to 75 grams of protein a day. High protein foods include eggs, meats, fish, seafood, tuna, poultry, tofu, milk, soy, cottage cheese, and yogurt. 30g of each daily intake of protein will be provided by a powdered protein supplement. Each subject will utilize a 30g serving of whey isolate for 6 weeks of their study and for the other 6 weeks the subject will use a single serving (1tablespoon) of Genepro Gen2 Protein.

Subject were given the following eating guidelines:

  • Eat slowly and chew small bites of food thoroughly.
  • Avoid rice, bread, raw vegetables, fresh fruits, and meats that are not easily chewed such as pork and steak. Ground meats are usually better tolerated.
  • With soft and solid foods, take only three bites at one sitting, then wait a minimum of 20 minutes before eating more.
  • Eat balanced meals with small portions.
  • Avoid the use of drinking straws and carbonated beverages, chewing gum and ice because they can introduce too much air into your pouch and cause discomfort.
  • Avoid sugar, sugar-containing foods and beverages, concentrated sweets, and fruit juices Alcoholic beverages will have a more profound effect and should be avoided or consumed with caution.

Exercise: Each subject is asked to exercise for 30 to 45 minutes a day, with cardio or aerobic activity three to five times a week. Initially, we recommend walking five minutes in the morning and five minutes in the late afternoon. As tolerated you should increase these intervals by five minutes until you are walking at least 15 minutes twice per day.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Genepro Gen2 Equivalency Study as Compared to Whey Isolate (1 Tablespoon of Genepro Gen2 and 30g Whey Isolate.
Study Start Date : June 2016
Actual Primary Completion Date : September 2016
Actual Study Completion Date : September 2016
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Active Comparator: Genepro Gen2 Protein

1 tablespoon Serving of Genepro Gen2 Protein daily will be used in each subject.

Intervention: Weekly blood draws will determine the effect on blood protein levels.

 Dietary Supplement: Genepro Protein
weekly blood draws to measure blood protein levels
Other Name: Genepro
Active Comparator: Whey Protein Isolate

30g Serving of Whey Isolate Protein will be used daily in each subject.

Intervention: Weekly blood draws will determine the effect on blood protein levels.

 Dietary Supplement: Whey Protein
weekly blood draws to measure blood protein levels
Other Name: Whey Protein Isolate


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Weekly Blood Draws to Measure Blood Protein Levels [ Time Frame: 6 weeks per intervention ]

    Each week the 20 participants will have blood drawn to measure their blood protein levels.

    Each participant was required to give blood weekly to determine the blood protein levels. The results show the average over each six week period of testing for each row. Each participant was examined to see if they achieved the average range as set fourth by the dieticians of greater than 6.1 and less than 8.7 within a 10% variable as acceptable.

    10 Participants will be given Genepro Gen2 for the first six weeks of the study and whey protein for the final 6.

    10 Participants will be given when protein for the first six weeks of the study and Genepro Gen2 for the final 6.

    These measurements will read in g/dl



Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years to 46 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria
  • 20 Post Op Gastric Bypass patients.
  • 10 men,
  • 10 women.
  • Minimum age 30
  • Maximum age 46
  • All participants have been post operation from their weight loss surgery for a minimum of 3 months prior to the start of the study and no longer than 12 months at the start of the study.

Exclusion Criteria:

  • Any digestive distress disorder (IBS, Crones, etc).
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02919657


Sponsors and Collaborators
Musclegen Research, Inc.
Investigators
Layout table for investigator information
Principal Investigator: David Michael, RN Musclegen Research, Inc.
Study Director: Brian M Parks, PHD MedFit Rx, Inc.
Principal Investigator: Tony R Parks, BS MedFit Rx, Inc.
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Musclegen Research, Inc.
ClinicalTrials.gov Identifier: NCT02919657    
Other Study ID Numbers: Genepro Gen 2
First Posted: September 29, 2016    Key Record Dates
Results First Posted: December 1, 2016
Last Update Posted: April 24, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: 10 subjects will be administered genepro for the first 6 weeks of the study and whey protein the last 6 week. The other 10 subjects will be administered whey protein for the first 6 weeks of the study and Genepro Gen2 for the last 6 weeks. Weekly blood draws will be taken from each subject to analyze blood protein levels.